Tumor hypoxia is a common feature of prostate tumors associated with the stabilization of hypoxia-inducible-factor 1alpha (HIF-1α) and poor prognosis following radiation therapy. Lack of oxygen at the time of irradiation is associated with radioresistance, but recent reports suggest radioresponse is also modulated by the dynamic nature of tumor hypoxia.
Derek Hennessey, Lynn Martin, Anne Atzberger, Thomas Lynch, Donal Hollywood and Laure Marignol
Download Paper
Spotlight on Precision Dermatology: Texas Physicians Work Together to Expand NMSC Treatment Options
One common question dermatologists often ask about incorporating radiation therapy into their practice is “How much involvement do I need from a radiation oncologist?” Regulations concerning physician supervision, reimbursement, and radiation shielding can vary quite...
